Alexander V. Uihlein

Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial

Benjamin Z. Leder, Joy N. Tsai, Alexander V. Uihlein et al. · The Lancet · 2015 · 557 citations · Full text

Bone Disease, Teriparatide Transitions, Data-switch Study +9

Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial

Joy N. Tsai, Alexander V. Uihlein, Hang Lee et al. · The Lancet · 2013 · 475 citations

Bone Disease, Bone Health, Osteopathy +11

Two Years of Denosumab and Teriparatide Administration in Postmenopausal Women With Osteoporosis (The DATA Extension Study): A Randomized Controlled Trial

Benjamin Z. Leder, Joy N. Tsai, Alexander V. Uihlein et al. · The Journal of Clinical Endocrinology & Metabolism · 2014 · 269 citations · Full text

Comparative Effects of Teriparatide, Denosumab, and Combination Therapy on Peripheral Compartmental Bone Density, Microarchitecture, and Estimated Strength: the DATA-HRpQCT Study

Joy N. Tsai, Alexander V. Uihlein, Sherri‐Ann M. Burnett‐Bowie et al. · Journal of Bone and Mineral Research · 2014 · 140 citations · Full text

Effects of Two Years of Teriparatide, Denosumab, or Both on Bone Microarchitecture and Strength (DATA-HRpQCT study)

Joy N. Tsai, Alexander V. Uihlein, Sherri‐Ann M. Burnett‐Bowie et al. · The Journal of Clinical Endocrinology & Metabolism · 2016 · 115 citations · Full text